📰 ET Markets 🟢 BULLISH 🕒 24 Oct 2026, 09:23 AM IST

DRL says cap on trade margins a positive, posts 36% dip in Q2 PAT

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: DRL says cap on trade margins a positive, posts 36% dip in Q2 PAT

📊

Market & Financial Impact: In the second quarter of FY2027, Dr. Reddy's Labs experienced a downturn in both revenue and profit. However, the company supports new trade margin regulations that aim to improve access to vital medicines. With a commitment to boosting its core business performance, management is also dedicated to exploring growth avenues.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Dr. Reddy's announced for the second quarter of FY2027 its revenue fell 1.5% to ₹8,671 crore while the profit after tax fell 36% to ₹925 crore versus ₹1,437 crore in the previous year.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

KYB and KYC: Business behind the wealth creator called ‘Divi’s Lab’ – Part 2, concluding

KYB and KYC: Business behind the wealth creator called “Divi’s Lab” – Part 1

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

DRL says cap on trade margins a positive, posts 36% dip in Q2 PAT

🔥 More Live Market Stories

[MARUTI] Press Release - Maruti Suzuki India Limited

Moneycontrol Pro Weekender | Don’t panic

Trump Administration Rolls Back Some Canada Tariffs - Talk 650 KSTE

Trump Administration Rolls Back Some Canada Tariffs - Newsradio 600 KOGO

Growth, value stocks set for reshuffle as S&P adopts new rules

Sensex, Nifty snap 2-week rally as oil shock, FII selling weigh on D-Street